Forbes India 30 Under 30 2023

From Covishield to Novovax: Who will make how many vaccine vials to reach India's 200 crore doses mark

As India reiterates its vaccine policy with an ambitious target of 200 crore doses by year-end, a look at how many vials will be likely made available by each of these seven manufacturers in the August to December 2021 period

Published: Jun 9, 2021 07:47:57 PM IST
Updated: Jun 10, 2021 10:56:14 AM IST

From Covishield to Novovax: Who will make how many vaccine vials to reach India's 200 crore doses mark

Infographic by Ruchika Shah.

Images from AFP, Getty Images, and Shutterstock.

Check out our Festive offers upto Rs.1000/- off website prices on subscriptions + Gift card worth Rs 500/- from Eatbetterco.com. Click here to know more.

Post Your Comment
Required
Required, will not be published
All comments are moderated